Longevity Startup Doses First Human in Bid to Reverse Age-Associated Sight Loss
A long life startup has dosed its first affected person with a drug to reverse age-related sight loss. Life Biosciences is testing its ER-100 drug,...
contenta-verify-dbb69181ba63e3b7